lobbying_activities: 590617
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 590617 | e65c11f7-79ec-4635-b361-449d83baee59 | Q1 | FORSCEY, PLLC | 52880 | BARR LABORATORIES | 2008 | first_quarter | CPT | Opposition to changes in legal doctrines of inequitable conduct that would make it harder for generic drug firms to pursue invalidity claims; S. 1145 Patent Reform Act of 2007. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2008-04-15T17:13:31-04:00 |